13F-HR filed by Atle Fund Management AB
Atle Fund Management AB filed this 13F-HR for the quarter ended 2023-12-31, filed 2024-01-30, with 45 holding rows worth $127,752,976.
- Accession
- 0001381843-24-000002
- Filer
- CIK 1381843
- Filed
- 2024-01-30
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2023
A holdings report, 45 entries on the cover page, a total value of $127,752,976 stated on the cover page (in dollars after the unit check, H1), rows summing to $127,752,976 with VALUE read as dollars as filed, 13F file number 028-12171. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| UnitedHealth Group Inc | 91324P102 | COM | 18,408 | $9,691,260 | dollars as filed | |
| Eli Lilly and Company | 532457108 | COM | 15,805 | $9,213,051 | dollars as filed | |
| Gilead Sciences,Inc. | 375558103 | COM | 98,974 | $8,017,884 | dollars as filed | |
| CENCORA INC COM | 03073E105 | Stock | 38,925 | $7,994,417 | dollars as filed | |
| Merck & Co.,Inc. | 58933Y105 | COM | 65,675 | $7,159,889 | dollars as filed | |
| Thermo Fisher Scientific Inc. | 883556102 | COM | 11,415 | $6,058,968 | dollars as filed | |
| CARDINAL HEALTH INC | 14149Y108 | COM | 48,000 | $4,838,400 | dollars as filed | |
| HARMONY BIOSCIENCES HLDGS IN | 413197104 | COM | 145,000 | $4,683,500 | dollars as filed | |
| Amgen Inc. | 031162100 | COM | 16,023 | $4,614,944 | dollars as filed | |
| CENTENE CORP DEL COM | 15135B101 | Stock | 62,000 | $4,601,020 | dollars as filed | |
| MOLINA HEALTHCARE INC | 60855R100 | COM | 12,500 | $4,516,375 | dollars as filed | |
| Bristol-Myers Squibb Company | 110122108 | COM | 88,000 | $4,515,280 | dollars as filed | |
| Cigna Corporation | 125523100 | COM | 15,000 | $4,491,750 | dollars as filed | |
| Elevance Health, Inc. | 036752103 | COM | 9,500 | $4,479,820 | dollars as filed | |
| Stryker Corporation | 863667101 | COM | 12,802 | $3,833,687 | dollars as filed | |
| Boston Scientific Corporation | 101137107 | COM | 64,806 | $3,746,435 | dollars as filed | |
| Vertex Pharmaceuticals Incorporated | 92532F100 | COM | 9,130 | $3,714,906 | dollars as filed | |
| REGENERON PHARMACEUTICALS COM | 75886F107 | Stock | 3,979 | $3,494,716 | dollars as filed | |
| AbbVie,Inc. | 00287Y109 | COM | 21,196 | $3,284,744 | dollars as filed | |
| IQVIA HLDGS INC COM | 46266C105 | Stock | 10,340 | $2,392,469 | dollars as filed | |
| DEXCOM INC COM | 252131107 | Stock | 18,057 | $2,240,693 | dollars as filed | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 12,617 | $1,662,416 | dollars as filed | |
| EDWARDS LIFESCIENCES CORP COM | 28176E108 | Stock | 20,815 | $1,587,144 | dollars as filed | |
| OPTION CARE HEALTH INC COM NEW | 68404L201 | Stock | 37,223 | $1,254,043 | dollars as filed | |
| Pfizer Inc. | 717081103 | COM | 42,820 | $1,232,788 | dollars as filed | |
| IONIS PHARMACEUTICALS INC COM | 462222100 | Stock | 24,243 | $1,226,453 | dollars as filed | |
| FUSION PHARMACEUTICALS INC | 36118A100 | COM | 125,000 | $1,201,250 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 11,733 | $979,588 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 23,985 | $968,274 | dollars as filed | |
| EXACT SCIENCES CORP COM | 30063P105 | Stock | 12,157 | $899,375 | dollars as filed | |
| INTRA-CELLULAR THERAPIES INC | 46116X101 | COMMON STOCK | 12,245 | $876,987 | dollars as filed | |
| AMBRX BIOPHARMA INC | 641871108 | COM | 57,847 | $823,741 | dollars as filed | |
| KRYSTAL BIOTECH INC COM | 501147102 | Stock | 6,624 | $821,773 | dollars as filed | |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 48,710 | $691,195 | dollars as filed | |
| SHOCKWAVE MED INC | 82489T104 | COM | 3,530 | $672,677 | dollars as filed | |
| MERUS N V | N5749R100 | COM | 24,325 | $668,938 | dollars as filed | |
| INSPIRE MED SYS INC COM | 457730109 | Stock | 3,229 | $656,875 | dollars as filed | |
| ARCELLX INC COMMON STOCK | 03940C100 | Stock | 11,400 | $632,700 | dollars as filed | |
| AUTOLUS THERAPEUTICS PLC SPON | 05280R100 | COM | 96,345 | $620,462 | dollars as filed | |
| MADRIGAL PHARMACEUTICALS INC COM | 558868105 | Stock | 2,531 | $585,623 | dollars as filed | |
| IMMUNOCORE HLDGS PLC ADS | 45258D105 | ADR | 7,823 | $534,467 | dollars as filed | |
| CABALETTA BIO INC | 12674W109 | COMMON STOCK | 21,000 | $476,700 | dollars as filed | |
| MORPHIC HLDG INC | 61775R105 | COM | 14,952 | $431,814 | dollars as filed | |
| AKERO THERAPEUTICS INC | 00973Y108 | COM | 15,432 | $360,337 | dollars as filed | |
| PROTHENA CORP PLC SHS | G72800108 | Stock | 8,342 | $303,148 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001381843-24-000002 | this filing | 2024-01-30 | acceptance time not in the bulk data set |